Cloaked, you have hit the nail right on the head, as we say.
This is the biggest news in the long history of Peregrine. The potential blockbuster cancer drug Bavituximab is one step from FDA approval. Most of us here clearly believe the clinical trial results suggest Bavi is at least as valuable as Avastin, more versatile and much safer. Very, very cool.
The BPs are fully aware of this. We might have a nice partnership soon, or we might see a buyout. I know a later buyout would be more lucrative, but a bird in the hand ...